Georges Moarbess

发表

Quantitation of imidazo[1,2-a]quinoxaline derivatives in human and rat plasma using LC/ESI-MS.

F. Pinguet, F. Bressolle, I. Solassol, 2009, Journal of separation science.

associated adult T-cell leukemia/lymphoma - HTLV-I and induces caspase-dependent apoptosis in T-cell lymphomas and EAPB0203, a member of the imidazoquinoxaline family, inhibits growth

Y. Kfoury, M. El-Sabban, A. Bazarbachi, 2013 .

EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase-dependent apoptosis in T-cell lymphomas and HTLV-I-associated adult T-cell leukemia/lymphoma.

Y. Kfoury, M. El-Sabban, A. Bazarbachi, 2008, Blood.

Size effect and mucus role on the intestinal toxicity of the E551 food additive and engineered silica nanoparticles

M. Diab-Assaf, N. Millot, Y. Pellequer, 2022, Nanotoxicology.

New imidazoquinoxaline derivatives: Synthesis, biological evaluation on melanoma, effect on tubulin polymerization and structure-activity relationships.

N. Bec, C. Larroque, P. Cuq, 2016, Bioorganic & medicinal chemistry.

Novel and selective TLR7 antagonists among the imidazo[1,2-a]pyrazines, imidazo[1,5-a]quinoxalines and pyrazolo[1,5-a]quinoxalines series.

P. Cuq, J. Guichou, I. Kassab, 2019, Journal of medicinal chemistry.

Preparation, characterization, and hydrogenation activity of new Rh 0 –MCM-41 catalysts prepared from as-synthesized MCM-41 and RhCl 3

F. Launay, Maya Boutros, T. Onfroy, 2018 .

New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.

F. Pinguet, F. Bressolle, S. Khier, 2009, European journal of medicinal chemistry.

New IKK inhibitors: Synthesis of new imidazo[1,2-a]quinoxaline derivatives using microwave assistance and biological evaluation as IKK inhibitors.

P. Cuq, J. Guichou, P. Bonnet, 2016, European journal of medicinal chemistry.

In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives.

F. Pinguet, F. Bressolle, P. Bonnet, 2008, Bioorganic & medicinal chemistry.

Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes

I. Kassab, P. Bonnet, Georges Moarbess, 2020, European Journal of Medicinal Chemistry.

Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma.

F. Pinguet, F. Bressolle, J. Cooper, 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Imidazo[1,2-a]pyrazine, Imidazo[1,5-a]quinoxaline and Pyrazolo[1,5-a]quinoxaline derivatives as IKK1 and IKK2 inhibitors.

P. Cuq, I. Kassab, P. Bonnet, 2017, European journal of medicinal chemistry.

Pharmacokinetic properties and metabolism of a new potent antimalarial N-alkylamidine compound, M64, and its corresponding bioprecursors.

H. Vial, F. Bressolle, Florence Gattacceca, 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

New imidazoquinoxaline derivatives: Synthesis, biological evaluation on melanoma, effect on tubulin polymerization and structure-activity relationships.

N. Bec, C. Larroque, P. Cuq, 2016, Bioorganic & medicinal chemistry.

Quantitation of imidazo[1,2-a]quinoxaline derivatives in human and rat plasma using LC/ESI-MS.

F. Pinguet, F. Bressolle, I. Solassol, 2009, Journal of separation science.

Methylation of imidazopyrazine, imidazoquinoxaline, and pyrazoloquinoxaline through Suzuki–Miyaura cross coupling

P. Cuq, I. Kassab, P. Bonnet, 2018, Chemistry of Heterocyclic Compounds.